Avadel Pharmaceuticals is a biopharmaceutical company focused on developing innovative treatments for patients with sleep disorders, specifically targeting conditions like narcolepsy and obstructive sleep apnea. The company leverages its proprietary drug delivery technology to create novel formulations designed to improve patient outcomes and enhance medication adherence. Avadel aims to address unmet medical needs through its advanced therapies while also pursuing strategic partnerships and collaborations to expand its product offerings and reach in the pharmaceutical market.